Carter Charles Ross (CIK 1779359) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-08). Recent activity: Buy OVID (50,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-08 | Ovid Therapeutics Inc. (OVID) | Chief Financial Officer | Buy | 50,000 | $0 |
Source: SEC Form 4 filings · as of 2026-07-08